Biggest changeHuntsman Corporation December 31, Percent change 2022 2021 2020 2022 vs 2021 2021 vs 2020 Revenues $ 8,023 $ 7,670 $ 5,421 5 % 41 % Cost of goods sold 6,477 6,086 4,444 6 % 37 % Gross profit 1,546 1,584 977 (2 )% 62 % Operating expenses 788 813 504 (3 )% 61 % Restructuring, impairment and plant closing costs 86 40 41 115 % (2 )% Operating income 672 731 432 (8 )% 69 % Interest expense, net (62 ) (67 ) (86 ) (7 )% (22 )% Equity in income of investment in unconsolidated affiliates 67 143 42 (53 )% 240 % Fair value adjustments to Venator investment, net and related loss on disposal (12 ) (28 ) (88 ) (57 )% (68 )% Loss on early extinguishment of debt — (27 ) — (100 )% NM (Costs) income associated with the Albemarle Settlement, net (3 ) 465 — NM NM Other income, net 35 29 31 21 % (6 )% Income from continuing operations before income taxes 697 1,246 331 (44 )% 276 % Income tax expense (186 ) (191 ) (42 ) (3 )% 355 % Income from continuing operations 511 1,055 289 (52 )% 265 % Income from discontinued operations, net of tax 12 49 777 (76 )% (94 )% Net income 523 1,104 1,066 (53 )% 4 % Reconciliation of net income to adjusted EBITDA: Net income attributable to noncontrolling interests (63 ) (59 ) (32 ) 7 % 84 % Interest expense, net from continuing operations 62 67 86 (7 )% (22 )% Income tax expense from continuing operations 186 191 42 (3 )% 355 % Income tax expense from discontinued operations 19 21 246 (10 )% (91 )% Depreciation and amortization of continuing operations 281 278 267 1 % 4 % Depreciation and amortization of discontinued operations 12 18 16 (33 )% 13 % Other adjustments: Business acquisition and integration expenses and purchase accounting inventory adjustments 12 22 31 EBITDA from discontinued operations (2) (43 ) (88 ) (1,039 ) Fair value adjustments to Venator investment, net and related loss on disposal 12 28 88 Loss on early extinguishment of debt — 27 — Certain legal and other settlements and related expenses 7 13 5 Costs (income) associated with the Albemarle Settlement, net 3 (465 ) — Gain on sale of businesses/assets — (30 ) (280 ) Income from transition services arrangements (2 ) (8 ) (7 ) Certain nonrecurring information technology project implementation costs 5 8 6 Amortization of pension and postretirement actuarial losses 49 74 64 Plant incident remediation (credits) costs (4 ) — 2 Restructuring, impairment and plant closing and transition costs (3) 96 45 44 Adjusted EBITDA (1) $ 1,155 $ 1,246 $ 605 (7 )% 106 % Net cash provided by operating activities from continuing operations $ 892 $ 915 $ 231 (3 )% 296 % Net cash (used in) provided by investing activities from continuing operations (260 ) (508 ) 1,474 (49 )% NM Net cash used in financing activities (994 ) (977 ) (655 ) 2 % 49 % Capital expenditures from continuing operations (272 ) (326 ) (237 ) (17 )% 38 % 26 Table of Contents Huntsman International December 31, Percent change 2022 2021 2020 2022 vs 2021 2021 vs 2020 Revenues $ 8,023 $ 7,670 $ 5,421 5 % 41 % Cost of goods sold 6,477 6,086 4,444 6 % 37 % Gross profit 1,546 1,584 977 (2 )% 62 % Operating expenses 784 806 498 (3 )% 62 % Restructuring, impairment and plant closing costs 86 40 41 115 % (2 )% Operating income 676 738 438 (8 )% 68 % Interest expense, net (62 ) (67 ) (88 ) (7 )% (24 )% Equity in income of investment in unconsolidated affiliates 67 143 42 (53 )% 240 % Fair value adjustments to Venator investment, net and related loss on disposal (12 ) (28 ) (88 ) (57 )% (68 )% Loss on early extinguishment of debt — (27 ) — (100 )% NM (Costs) income associated with the Albemarle Settlement, net (3 ) 465 — NM NM Other income, net 34 26 28 31 % (7 )% Income from continuing operations before income taxes 700 1,250 332 (44 )% 277 % Income tax expense (188 ) (192 ) (42 ) (2 )% 357 % Income from continuing operations 512 1,058 290 (52 )% 265 % Income from discontinued operations, net of tax 12 49 777 (76 )% (94 )% Net income 524 1,107 1,067 (53 )% 4 % Reconciliation of net income to adjusted EBITDA: Net income attributable to noncontrolling interests (63 ) (59 ) (32 ) 7 % 84 % Interest expense, net from continuing operations 62 67 88 (7 )% (24 )% Income tax expense (benefit) from continuing operations 188 192 42 (2 )% 357 % Income tax expense from discontinued operations 19 21 246 (10 )% (91 )% Depreciation and amortization of continuing operations 281 278 267 1 % 4 % Depreciation and amortization of discontinued operations 12 18 16 (33 )% 13 % Other adjustments: Business acquisition and integration expenses and purchase accounting inventory adjustments 12 22 31 EBITDA from discontinued operations (2) (43 ) (88 ) (1,039 ) Fair value adjustments to Venator investment, net and related loss on disposal 12 28 88 Loss on early extinguishment of debt — 27 — Certain legal and other settlements and related expenses 7 13 5 Costs (income) associated with the Albemarle Settlement, net 3 (465 ) — Gain on sale of businesses/assets — (30 ) (280 ) Income from transition services arrangements (2 ) (8 ) (7 ) Certain nonrecurring information technology project implementation costs 5 8 6 Amortization of pension and postretirement actuarial losses 49 76 67 Plant incident remediation (credits) costs (4 ) — 2 Restructuring, impairment and plant closing and transition costs (3) 96 45 44 Adjusted EBITDA (1) $ 1,158 $ 1,252 $ 611 (8 )% 105 % Net cash provided by operating activities from continuing operations $ 895 $ 918 $ 233 (3 )% 294 % Net cash (used in) provided by investing activities from continuing operations (1,277 ) (710 ) 1,748 80 % NM Net cash provided by (used in) financing activities 22 (778 ) (933 ) NM (17 )% Capital expenditures from continuing operations (272 ) (326 ) (237 ) (17 )% 38 % 27 Table of Contents Huntsman Corporation Year ended Year ended Year ended December 31, 2022 December 31, 2021 December 31, 2020 Tax Tax Tax Gross and other(4) Net Gross and other(4) Net Gross and other(4) Net Reconciliation of net income to adjusted net income Net income $ 523 $ 1,104 $ 1,066 Net income attributable to noncontrolling interests (63 ) (59 ) (32 ) Business acquisition and integration expenses and purchase accounting inventory adjustments $ 12 $ (2 ) 10 $ 22 $ (6 ) 16 $ 31 $ (6 ) 25 Income from discontinued operations (2)(5) (43 ) 31 (12 ) (88 ) 39 (49 ) (1,039 ) 262 (777 ) Fair value adjustments to Venator investment, net and related loss on disposal 12 — 12 28 — 28 88 (9 ) 79 Loss on early extinguishment of debt — — — 27 (6 ) 21 — — — Certain legal and other settlements and related expenses 7 (2 ) 5 13 (3 ) 10 5 (1 ) 4 Costs (income) associated with the Albemarle Settlement, net 3 (1 ) 2 (465 ) 55 (410 ) — — — Gain on sale of businesses/assets — — — (30 ) 3 (27 ) (280 ) 31 (249 ) Income from transition services arrangements (2 ) — (2 ) (8 ) 2 (6 ) (7 ) 2 (5 ) Certain nonrecurring information technology project implementation costs 5 (1 ) 4 8 (2 ) 6 6 (1 ) 5 Amortization of pension and postretirement actuarial losses 49 (11 ) 38 74 (16 ) 58 64 (14 ) 50 Plant incident remediation (credits) costs (4 ) 1 (3 ) — — — 2 — 2 Establishment of significant deferred tax asset valuation allowance (6) — 49 49 — — — — — — Restructuring, impairment and plant closing and transition costs (3) 96 (23 ) 73 45 (11 ) 34 44 (11 ) 33 Adjusted net income (1) $ 636 $ 726 $ 201 Weighted average shares-basic 201.0 219.2 220.6 Weighted average shares-diluted 203.0 221.4 221.9 Basic net income attributable to Huntsman Corporation per share: Income from continuing operations $ 2.23 $ 4.55 $ 1.17 Income from discontinued operations 0.06 0.22 3.52 Net income $ 2.29 $ 4.77 $ 4.69 Diluted net income attributable to Huntsman Corporation per share: Income from continuing operations $ 2.21 $ 4.50 $ 1.16 Income from discontinued operations 0.06 0.22 3.50 Net income $ 2.27 $ 4.72 $ 4.66 Other non-GAAP measures: Diluted adjusted net income per share (1) $ 3.13 $ 3.28 $ 0.91 Net cash provided by operating activities from continuing operations $ 892 $ 915 $ 231 Capital expenditures from continuing operations (272 ) (326 ) (237 ) Free cash flow from continuing operations (1) $ 620 $ 589 $ (6 ) Effective tax rate 27 % 15 % 13 % Impact of non-GAAP adjustments (7) (7 )% 3 % 5 % Adjusted effective tax rate (1) 20 % 18 % 18 % Other cash flow measure: Net cash proceeds from the Albemarle Settlement (8) $ 78 $ 333 $ — Taxes paid on sale of businesses (9) — (3 ) (257 ) NM—Not meaningful (1) See “—Non-GAAP Financial Measures.” (2) Includes the gain on the sale of our Chemical Intermediates Businesses in 2020.
Biggest changeHuntsman Corporation December 31, Percent change 2023 2022 2021 2023 vs 2022 2022 vs 2021 Revenues $ 6,111 $ 8,023 $ 7,670 (24 )% 5 % Cost of goods sold 5,205 6,477 6,086 (20 )% 6 % Gross profit 906 1,546 1,584 (41 )% (2 )% Operating expenses 804 788 813 2 % (3 )% Restructuring, impairment and plant closing costs 18 86 40 (79 )% 115 % Operating income 84 672 731 (88 )% (8 )% Interest expense, net (65 ) (62 ) (67 ) 5 % (7 )% Equity in income of investment in unconsolidated affiliates 83 67 143 24 % (53 )% Fair value adjustments to Venator investment, net (5 ) (12 ) (28 ) (58 )% (57 )% Loss on early extinguishment of debt — — (27 ) — (100 )% (Costs) income associated with the Albemarle Settlement, net — (3 ) 465 (100 )% NM Other income, net 2 35 29 (94 )% 21 % Income from continuing operations before income taxes 99 697 1,246 (86 )% (44 )% Income tax expense (64 ) (186 ) (191 ) (66 )% (3 )% Income from continuing operations 35 511 1,055 (93 )% (52 )% Income from discontinued operations, net of tax 118 12 49 883 % (76 )% Net income 153 523 1,104 (71 )% (53 )% Reconciliation of net income to adjusted EBITDA: Net income attributable to noncontrolling interests (52 ) (63 ) (59 ) (17 )% 7 % Interest expense, net from continuing operations 65 62 67 5 % (7 )% Income tax expense from continuing operations 64 186 191 (66 )% (3 )% Income tax expense from discontinued operations 17 19 21 (11 )% (10 )% Depreciation and amortization of continuing operations 278 281 278 (1 )% 1 % Depreciation and amortization of discontinued operations — 12 18 (100 )% (33 )% Other adjustments: Business acquisition and integration expenses and purchase accounting inventory adjustments 4 12 22 EBITDA from discontinued operations (2) (135 ) (43 ) (88 ) Fair value adjustments to Venator investment, net 5 12 28 Loss on early extinguishment of debt — — 27 Certain legal and other settlements and related expenses 6 7 13 Costs (income) associated with the Albemarle Settlement, net — 3 (465 ) Gain on sale of businesses/assets — — (30 ) Income from transition services arrangements — (2 ) (8 ) Certain nonrecurring information technology project implementation costs 5 5 8 Amortization of pension and postretirement actuarial losses 37 49 74 Plant incident remediation credits — (4 ) — Restructuring, impairment and plant closing and transition costs (3) 25 96 45 Adjusted EBITDA (1) $ 472 $ 1,155 $ 1,246 (59 )% (7 )% Net cash provided by operating activities from continuing operations $ 251 $ 892 $ 915 (72 )% (3 )% Net cash provided by (used in) investing activities from continuing operations 309 (260 ) (508 ) NM (49 )% Net cash used in financing activities (620 ) (994 ) (977 ) (38 )% 2 % Capital expenditures from continuing operations (230 ) (272 ) (326 ) (15 )% (17 )% 26 Table of Contents Huntsman International December 31, Percent change 2023 2022 2021 2023 vs 2022 2022 vs 2021 Revenues $ 6,111 $ 8,023 $ 7,670 (24 )% 5 % Cost of goods sold 5,205 6,477 6,086 (20 )% 6 % Gross profit 906 1,546 1,584 (41 )% (2 )% Operating expenses 801 784 806 2 % (3 )% Restructuring, impairment and plant closing costs 18 86 40 (79 )% 115 % Operating income 87 676 738 (87 )% (8 )% Interest expense, net (65 ) (62 ) (67 ) 5 % (7 )% Equity in income of investment in unconsolidated affiliates 83 67 143 24 % (53 )% Fair value adjustments to Venator investment, net (5 ) (12 ) (28 ) (58 )% (57 )% Loss on early extinguishment of debt — — (27 ) — (100 )% (Costs) income associated with the Albemarle Settlement, net — (3 ) 465 (100 )% NM Other income, net 2 34 26 (94 )% 31 % Income from continuing operations before income taxes 102 700 1,250 (85 )% (44 )% Income tax expense (65 ) (188 ) (192 ) (65 )% (2 )% Income from continuing operations 37 512 1,058 (93 )% (52 )% Income from discontinued operations, net of tax 118 12 49 883 % (76 )% Net income 155 524 1,107 (70 )% (53 )% Reconciliation of net income to adjusted EBITDA: Net income attributable to noncontrolling interests (52 ) (63 ) (59 ) (17 )% 7 % Interest expense, net from continuing operations 65 62 67 5 % (7 )% Income tax expense from continuing operations 65 188 192 (65 )% (2 )% Income tax expense from discontinued operations 17 19 21 (11 )% (10 )% Depreciation and amortization of continuing operations 278 281 278 (1 )% 1 % Depreciation and amortization of discontinued operations — 12 18 (100 )% (33 )% Other adjustments: Business acquisition and integration expenses and purchase accounting inventory adjustments 4 12 22 EBITDA from discontinued operations (2) (135 ) (43 ) (88 ) Fair value adjustments to Venator investment, net 5 12 28 Loss on early extinguishment of debt — — 27 Certain legal and other settlements and related expenses 6 7 13 Costs (income) associated with the Albemarle Settlement, net — 3 (465 ) Gain on sale of businesses/assets — — (30 ) Income from transition services arrangements — (2 ) (8 ) Certain nonrecurring information technology project implementation costs 5 5 8 Amortization of pension and postretirement actuarial losses 37 49 76 Plant incident remediation credits — (4 ) — Restructuring, impairment and plant closing and transition costs (3) 25 96 45 Adjusted EBITDA (1) $ 475 $ 1,158 $ 1,252 (59 )% (8 )% Net cash provided by operating activities from continuing operations $ 253 $ 895 $ 918 (72 )% (3 )% Net cash used in investing activities from continuing operations (42 ) (1,277 ) (710 ) (97 )% 80 % Net cash (used in) provided by financing activities (271 ) 22 (778 ) NM NM Capital expenditures from continuing operations (230 ) (272 ) (326 ) (15 )% (17 )% 27 Table of Contents Huntsman Corporation Year ended Year ended Year ended December 31, 2023 December 31, 2022 December 31, 2021 Tax Tax Tax Gross and other (4) Net Gross and other (4) Net Gross and other (4) Net Reconciliation of net income to adjusted net income Net income $ 153 $ 523 $ 1,104 Net income attributable to noncontrolling interests (52 ) (63 ) (59 ) Business acquisition and integration expenses and purchase accounting inventory adjustments $ 4 $ (1 ) 3 $ 12 $ (2 ) 10 $ 22 $ (6 ) 16 Income from discontinued operations (2)(5) (135 ) 17 (118 ) (43 ) 31 (12 ) (88 ) 39 (49 ) Fair value adjustments to Venator investment, net 5 — 5 12 — 12 28 — 28 Loss on early extinguishment of debt — — — — — — 27 (6 ) 21 Certain legal and other settlements and related expenses 6 (1 ) 5 7 (2 ) 5 13 (3 ) 10 Costs (income) associated with the Albemarle Settlement, net — — — 3 (1 ) 2 (465 ) 55 (410 ) Gain on sale of businesses/assets — — — — — — (30 ) 3 (27 ) Income from transition services arrangements — — — (2 ) — (2 ) (8 ) 2 (6 ) Certain nonrecurring information technology project implementation costs 5 (1 ) 4 5 (1 ) 4 8 (2 ) 6 Amortization of pension and postretirement actuarial losses 37 (6 ) 31 49 (11 ) 38 74 (16 ) 58 Plant incident remediation credits — — — (4 ) 1 (3 ) — — — Establishment of significant deferred tax asset valuation allowance (6) — 14 14 — 49 49 — — — Restructuring, impairment and plant closing and transition costs (3) 25 (3 ) 22 96 (23 ) 73 45 (11 ) 34 Adjusted net income (1) $ 67 $ 636 $ 726 Weighted average shares-basic 177.4 201.0 219.2 Weighted average shares-diluted 177.4 203.0 221.4 Basic net income attributable to Huntsman Corporation per share: Income from continuing operations $ (0.10 ) $ 2.23 $ 4.55 Income from discontinued operations 0.67 0.06 0.22 Net income $ 0.57 $ 2.29 $ 4.77 Diluted net income attributable to Huntsman Corporation per share: Income from continuing operations $ (0.10 ) $ 2.21 $ 4.50 Income from discontinued operations 0.67 0.06 0.22 Net income $ 0.57 $ 2.27 $ 4.72 Other non-GAAP measures: Diluted adjusted net income per share (1) $ 0.37 $ 3.13 $ 3.28 Net cash provided by operating activities from continuing operations $ 251 $ 892 $ 915 Capital expenditures from continuing operations (230 ) (272 ) (326 ) Free cash flow from continuing operations (1) $ 21 $ 620 $ 589 Effective tax rate 65 % 27 % 15 % Impact of non-GAAP adjustments (7) (31 )% (7 )% 3 % Adjusted effective tax rate (1) 34 % 20 % 18 % NM—Not meaningful (1) See “—Non-GAAP Financial Measures.” (2) Includes the gain on the sale of our Textile Effects Business in 2023.
Management internally uses a free cash flow measure: (a) to evaluate our liquidity, (b) evaluate strategic investments, (c) plan stock buyback and dividend levels and (d) evaluate our ability to incur and service debt. 29 Table of Contents Adjusted Effective Tax Rate We believe that the effective tax rate of Huntsman Corporation or Huntsman International, as appropriate, is the performance measure calculated and presented in accordance with U.S.
Management internally uses a free cash flow measure: (a) to evaluate our liquidity, (b) evaluate strategic investments, (c) plan dividend and stock buyback levels and (d) evaluate our ability to incur and service debt. 29 Table of Contents Adjusted Effective Tax Rate We believe that the effective tax rate of Huntsman Corporation or Huntsman International, as appropriate, is the performance measure calculated and presented in accordance with U.S.
Adjusted Net Income Adjusted net income is computed by eliminating the after tax amounts related to the following from net income attributable to Huntsman Corporation: (a) business acquisition and integration expenses and purchase accounting inventory adjustments; (b) income from discontinued operations; (c) fair value adjustments to Venator investment, net and related loss on disposal; (d) loss on early extinguishment of debt; (e) certain legal and other settlements and related expenses; (f) costs (income) associated with the Albemarle Settlement, net; (g) gain on sale of businesses/assets; (h) income from transition services arrangements associated with the sale of our Chemical Intermediates Businesses to Indorama; (i) certain nonrecurring information technology project implementation costs; (j) amortization of pension and postretirement actuarial losses; (k) plant incident remediation (credits) costs; (l) establishment of significant deferred tax asset valuation allowance; and (m) restructuring, impairment and plant closing and transition costs.
Adjusted Net Income Adjusted net income is computed by eliminating the after tax amounts related to the following from net income attributable to Huntsman Corporation: (a) business acquisition and integration expenses and purchase accounting inventory adjustments; (b) income from discontinued operations; (c) fair value adjustments to Venator investment, net; (d) loss on early extinguishment of debt; (e) certain legal and other settlements and related expenses; (f) costs (income) associated with the Albemarle Settlement, net; (g) gain on sale of businesses/assets; (h) income from transition services arrangements associated with the sale of our Chemical Intermediates Businesses to Indorama; (i) certain nonrecurring information technology project implementation costs; (j) amortization of pension and postretirement actuarial losses; (k) plant incident remediation credits; (l) establishment of significant deferred tax asset valuation allowance; and (m) restructuring, impairment and plant closing and transition costs.
We disclose forward-looking adjusted effective tax rate because we cannot adequately forecast certain items and events that may or may not impact us in the near future, such as business acquisition and integration expenses and purchase accounting inventory adjustments, certain legal and other settlements and related expenses, gains on sale of businesses/assets and certain tax only items, including tax law changes not yet enacted.
We disclose forward-looking adjusted effective tax rate because we cannot adequately forecast certain items and events that may or may not impact us in the near future, such as business acquisition and integration expenses and purchase accounting inventory adjustments, certain legal and other settlements and related expenses, gain on sale of businesses/assets and certain tax only items, including tax law changes not yet enacted.
Debt” to our consolidated financial statements. 36 Table of Contents C ritical A ccounting E st imates This discussion and analysis of financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America.
Debt” to our consolidated financial statements. 33 Table of Contents C ritical A ccounting E st imates This discussion and analysis of financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America.
Adjusted EBITDA is defined as net income of Huntsman Corporation or Huntsman International, as appropriate, before interest, income tax, depreciation and amortization, net income attributable to noncontrolling interests and certain Corporate and other items, as well as eliminating the following adjustments: (a) business acquisition and integration expenses and purchase accounting inventory adjustments; (b) EBITDA from discontinued operations; (c) fair value adjustments to Venator investment, net and related loss on disposal; (d) loss on early extinguishment of debt; (e) certain legal and other settlements and related expenses; (f) costs (income) associated with the Albemarle Settlement, net; (g) gain on sale of businesses/assets; (h) income from transition services arrangements related to the sale of our Chemical Intermediates Businesses to Indorama; (i) certain nonrecurring information technology project implementation costs; (j) amortization of pension and postretirement actuarial losses; (k) plant incident remediation (credits) costs; and (l) restructuring, impairment and plant closing and transition costs.
Adjusted EBITDA is defined as net income of Huntsman Corporation or Huntsman International, as appropriate, before interest, income tax, depreciation and amortization, net income attributable to noncontrolling interests and certain Corporate and other items, as well as eliminating the following adjustments: (a) business acquisition and integration expenses and purchase accounting inventory adjustments; (b) EBITDA from discontinued operations; (c) fair value adjustments to Venator investment, net; (d) loss on early extinguishment of debt; (e) certain legal and other settlements and related expenses; (f) costs (income) associated with the Albemarle Settlement, net; (g) gain on sale of businesses/assets; (h) income from transition services arrangements; (i) certain nonrecurring information technology project implementation costs; (j) amortization of pension and postretirement actuarial losses; (k) plant incident remediation credits; and (l) restructuring, impairment and plant closing and transition costs.
For each of our Company and Huntsman International, the following tables set forth our consolidated results of operations for the years ended December 31, 2022, 2021 and 2020 (dollars in millions, except per share amounts).
For each of our Company and Huntsman International, the following tables set forth our consolidated results of operations for the years ended December 31, 2023, 2022 and 2021 (dollars in millions, except per share amounts).
We believe our adjusted effective tax rate provides improved comparability between periods through the exclusion of certain items, such as, business acquisition and integration expenses and purchase accounting inventory adjustments, certain legal and other settlements and related expenses, gains on sale of businesses/assets and certain tax only items, including tax law changes not yet enacted and certain changes in valuation allowances that we believe are not indicative of the businesses’ operational profitability and that may obscure underlying business results and trends.
We believe our adjusted effective tax rate provides improved comparability between periods through the exclusion of certain items, such as, business acquisition and integration expenses and purchase accounting inventory adjustments, certain legal and other settlements and related expenses, gains on sale of businesses/assets and certain tax only items, such as certain changes in valuation allowances that we believe are not indicative of the businesses’ operational profitability and that may obscure underlying business results and trends.
Our future expenditures include certain environmental, health and safety upgrades; expansions of our existing manufacturing and other facilities; certain cost reduction projects, including those described below; and certain information technology expenditures.
Our future expenditures include certain environmental, health and safety upgrades; expansions and upgrades of our existing manufacturing and other facilities; construction of new facilities; certain cost reduction projects, including those described below; and certain information technology expenditures.
GAAP, which we supplement with certain non-GAAP financial information. These non-GAAP measures should not be considered in isolation or as a substitute for the related U.S. GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and the reconciliation of the non-GAAP financial measures to the most directly comparable U.S.
These non-GAAP measures should not be considered in isolation or as a substitute for the related U.S. GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and the reconciliation of the non-GAAP financial measures to the most directly comparable U.S.
Our working capital decreased by $433 million as a result of the net impact of the following significant changes: ● The decrease in cash and cash equivalents of $387 million resulted from the matters identified on our consolidated statements of cash flows.
Our working capital decreased by $302 million as a result of the net impact of the following significant changes: ● The decrease in cash and cash equivalents of $114 million resulted from the matters identified on our consolidated statements of cash flows.
Cash Flows For Year Ended December 31, 2022 Compared with Year Ended December 31, 2021 Net cash provided by operating activities from continuing operations for 2022 and 2021 was $892 million and $915 million, respectively.
Cash Flows For Year Ended December 31, 2023 Compared with Year Ended December 31, 2022 Net cash provided by operating activities from continuing operations for 2023 and 2022 was $251 million and $892 million, respectively.
As of December 31, 2022, we had total valuation allowances of $169 million, which represents an increase of $38 million from the prior year, and we have a recognized a net deferred tax liability of $103 million. See “Note 19. Income Taxes” to our consolidated financial statements for more information regarding our deferred tax assets and valuation allowances.
As of December 31, 2023, we had total valuation allowances of $221 million, which represents an increase of $52 million from the prior year, and we have a recognized a net deferred tax liability of $131 million. See “Note 19. Income Taxes” to our consolidated financial statements for more information regarding our deferred tax assets and valuation allowances.
Debt—Direct and Subsidiary Debt—Revolving Credit Facility” to our consolidated financial statements. ● On February 17, 2023, our Board of Directors declared a $0.2375 per share cash dividend on our common stock. This represents an approximate 12% increase from the previous dividend.
Debt—Direct and Subsidiary Debt—Revolving Credit Facility” to our consolidated financial statements. ● On February 16, 2024, our Board of Directors declared a $0.25 per share cash dividend on our common stock. This represents an approximate 5% increase from the previous dividend.
The decrease in net cash provided by operating activities from continuing operations during 2022 compared with 2021 was primarily attributable to decreased operating income as described in “—Results of Operations” above, partially offset by a net cash inflow of $357 million related to changes in operating assets and liabilities for 2022 as compared with 2021.
The decrease in net cash provided by operating activities from continuing operations during 2023 compared with 2022 was primarily attributable to decreased operating income as described in “—Results of Operations” above as well as a net cash outflow of $95 million related to changes in operating assets and liabilities for 2023 as compared with 2022.
As of December 31, 2022, we had $1,847 million of combined cash and unused borrowing capacity, consisting of $654 million in cash, $1,132 million in availability under our 2022 Revolving Credit Facility and $61 million in availability under our A/R Programs. Our liquidity can be significantly impacted by various factors.
As of December 31, 2023, we had $1,738 million of combined cash and unused borrowing capacity, consisting of $540 million in cash, $1,196 million in availability under our 2022 Revolving Credit Facility and $2 million in availability under our A/R Programs. Our liquidity can be significantly impacted by various factors.
Year ended December 31, 2022 vs 2021 Average selling prices(1) Local Foreign currency Sales Mix and currency translation impact volumes(2) other Period-over-period increase (decrease) Polyurethanes 16 % (5 )% (10 )% — Performance Products 27 % (3 )% (11 )% 2 % Advanced Materials 20 % (5 )% (19 )% 11 % (1) Excludes revenues from tolling arrangements, byproducts and raw materials.
Year ended December 31, 2023 vs 2022 Average selling prices (1) Local Foreign currency Sales Mix and currency translation impact volumes(2) other Period-over-period increase (decrease) Polyurethanes (10 )% (1 )% (10 )% (3 )% Performance Products (8 )% — (24 )% 1 % Advanced Materials 1 % — (18 )% 3 % (1) Excludes revenues from tolling arrangements, byproducts and raw materials.
The following matters are expected to have a significant impact on our liquidity: ● During 2023, we expect to spend between approximately $240 million to $250 million on capital expenditures.
The following matters are expected to have a significant impact on our liquidity: ● During 2024, we expect to spend approximately $200 million on capital expenditures.
The effect of a 1% change in three key assumptions is summarized as follows (dollars in millions): Statement of Balance sheet Assumptions operations(1) impact(2) Discount rate —1% increase $ (35 ) $ (227 ) —1% decrease 47 255 Expected long-term rates of return on plan assets —1% increase (31 ) — —1% decrease 31 — Rate of compensation increase —1% increase 9 24 —1% decrease (5 ) (22 ) (1) Estimated (decrease) increase on 2022 net periodic benefit cost (2) Estimated (decrease) increase on December 31, 2022 pension and postretirement liabilities and accumulated other comprehensive loss 37 Table of Contents
The effect of a 1% change in three key assumptions is summarized as follows (dollars in millions): Statement of Balance sheet Assumptions operations (1) impact (2) Discount rate —1% increase $ (16 ) $ (256 ) —1% decrease 18 302 Expected long-term rates of return on plan assets —1% increase (22 ) — —1% decrease 22 — Rate of compensation increase —1% increase 2 25 —1% decrease (5 ) (23 ) (1) Estimated (decrease) increase on 2023 net periodic benefit cost (2) Estimated (decrease) increase on December 31, 2023 pension and postretirement liabilities and accumulated other comprehensive loss 34 Table of Contents
Year Ended December 31, 2022 Compared with Year Ended December 31, 2021 For the year ended December 31, 2022, income from continuing operations attributable to Huntsman Corporation was $448 million, a decrease of $548 million from $996 million in the 2021 period.
Year Ended December 31, 2023 Compared with Year Ended December 31, 2022 For the year ended December 31, 2023, loss from continuing operations attributable to Huntsman Corporation was $17 million as compared with income of $448 million in the 2022 period.
The income tax expense of Huntsman International for the year ended December 31, 2022 decreased to $188 million from $192 million in the 2021 period. The decrease in income tax expense was primarily due to a decrease in income from continuing operations before income taxes offset by an increase in valuation allowance.
The income tax expense of Huntsman International for the year ended December 31, 2023 decreased to $65 million from $188 million in the 2022 period. The decrease in income tax expense was primarily due to the decrease in income from continuing operations before income taxes.
For 2022, adjusted EBITDA from Corporate and other for Huntsman Corporation increased by $21 million to a loss of $175 million from a loss of $196 million for 2021. For 2022, adjusted EBITDA from Corporate and other for Huntsman International increased by $18 million to a loss of $172 million from a loss of $190 million for 2021.
For 2023, adjusted EBITDA from Corporate and other for Huntsman Corporation increased by $12 million to a loss of $163 million from a loss of $175 million for 2022. For 2023, adjusted EBITDA from Corporate and other for Huntsman International increased by $12 million to a loss of $160 million from a loss of $172 million for 2022.
The increase in segment adjusted EBITDA was primarily due to increased sales revenue and margins, partially offset by higher fixed costs. Advanced Materials The increase in revenues in our Advanced Materials segment for 2022 compared to 2021 was primarily due to higher average selling prices, partially offset by lower sales volumes.
The decrease in segment adjusted EBITDA was primarily due to decreased sales volumes and lower average selling prices, partially offset by reduced fixed costs. Advanced Materials The decrease in revenues in our Advanced Materials segment for 2023 compared to 2022 was primarily due to lower sales volumes while average selling prices remained stable.
Income Taxes” to our consolidated financial statements. 30 Table of Contents Segment Analysis Year Ended December 31, 2022 Compared with Year Ended December 31, 2021 Percent change Year ended December 31, favorable (Dollars in millions) 2022 2021 (unfavorable) Revenues Polyurethanes $ 5,067 $ 5,019 1 % Performance Products 1,713 1,485 15 % Advanced Materials 1,277 1,198 7 % Total reportable segments’ revenues 8,057 7,702 5 % Intersegment eliminations (34 ) (32 ) NM Total $ 8,023 $ 7,670 5 % Huntsman Corporation Adjusted EBITDA (1) Polyurethanes $ 628 $ 879 (29 )% Performance Products 469 359 31 % Advanced Materials 233 204 14 % Total reportable segments’ adjusted EBITDA 1,330 1,442 (8 )% Corporate and other (175 ) (196 ) 11 % Total $ 1,155 $ 1,246 (7 )% Huntsman International Adjusted EBITDA (1) Polyurethanes $ 628 $ 879 (29 )% Performance Products 469 359 31 % Advanced Materials 233 204 14 % Total reportable segments’ adjusted EBITDA 1,330 1,442 (8 )% Corporate and other (172 ) (190 ) 9 % Total $ 1,158 $ 1,252 (8 )% NM—Not meaningful (1) For more information, including reconciliation of total reportable segments’ adjusted EBITDA to income from continuing operations before income taxes of Huntsman Corporation or Huntsman International, as appropriate, see “Note 26.
Income Taxes” to our consolidated financial statements. 30 Table of Contents Segment Analysis Year Ended December 31, 2023 Compared with Year Ended December 31, 2022 Percent change Year ended December 31, favorable (Dollars in millions) 2023 2022 (unfavorable) Revenues Polyurethanes $ 3,865 $ 5,067 (24 )% Performance Products 1,178 1,713 (31 )% Advanced Materials 1,092 1,277 (14 )% Total reportable segments’ revenues 6,135 8,057 (24 )% Intersegment eliminations (24 ) (34 ) NM Total $ 6,111 $ 8,023 (24 )% Huntsman Corporation Adjusted EBITDA (1) Polyurethanes $ 248 $ 628 (61 )% Performance Products 201 469 (57 )% Advanced Materials 186 233 (20 )% Total reportable segments’ adjusted EBITDA 635 1,330 (52 )% Corporate and other (163 ) (175 ) 7 % Total $ 472 $ 1,155 (59 )% Huntsman International Adjusted EBITDA (1) Polyurethanes $ 248 $ 628 (61 )% Performance Products 201 469 (57 )% Advanced Materials 186 233 (20 )% Total reportable segments’ adjusted EBITDA 635 1,330 (52 )% Corporate and other (160 ) (172 ) 7 % Total $ 475 $ 1,158 (59 )% NM—Not meaningful (1) For more information, including reconciliation of total reportable segments’ adjusted EBITDA to income from continuing operations before income taxes of Huntsman Corporation or Huntsman International, as appropriate, see “Note 26.
(2) Excludes sales volumes of byproducts and raw materials. Polyurethanes The increase in revenues in our Polyurethanes segment for 2022 compared to 2021 was primarily due to higher MDI average selling prices, partially offset by lower sales volumes and the negative impact of weaker major international currencies against the U.S. dollar.
(2) Excludes sales volumes of byproducts and raw materials. Polyurethanes The decrease in revenues in our Polyurethanes segment for 2023 compared to 2022 was primarily due to lower sales volumes, lower MDI average selling prices and the net negative impact of major foreign currency exchange rate movements against the U.S. dollar.
The decreases noted above were the result of the following items: ● Revenues for the year ended December 31, 2022 increased by $353 million, or 5%, as compared with the 2021 period. The increase was primarily due to higher average selling prices in all our segments, partially offset by lower sales volumes in all our segments.
The decreases noted above were the result of the following items: ● Revenues for the year ended December 31, 2023 decreased by $1,912 million, or 24%, as compared with the 2022 period. The decrease was primarily due to lower sales volumes in all our segments and lower average selling prices in all our segments, except for our Advanced Materials segment.
For the year ended December 31, 2022, income from continuing operations attributable to Huntsman International was $449 million, a decrease of $550 million from $999 million in the 2021 period.
For the year ended December 31, 2023, loss from continuing operations attributable to Huntsman International was $15 million, as compared with income of $449 million in the 2022 period.
Starting in the fourth quarter of 2021, we began to include income and costs associated with the Albemarle Settlement, net in our adjustments since such income and costs represents a one-time legal settlement and does not reflect our ongoing financial performance.
Starting in 2021, we began to include income and costs associated with the arbitration award we won in October 2021 in excess of $600 million against Albemarle Corporation (“Albemarle”) for fraud and breach of contract (the “Albemarle Settlement”), net in our adjustments since such income and costs represents a one-time legal settlement and does not reflect our ongoing financial performance.
See “—Segment Analysis” below. ● Gross profit for the year ended December 31, 2022 decreased by $38 million, or 2%, as compared with the 2021 period. The decrease resulted from lower gross profit in our Polyurethanes segment, partially offset by higher gross profits in our Performance Products and Advanced Materials segments.
See “—Segment Analysis” below. ● Gross profit for the year ended December 31, 2023 decreased by $640 million, or 41%, as compared with the 2022 period. The decrease resulted primarily from lower gross profits in all our segments.
The increase in free cash flow from continuing operations was primarily attributable to a decrease in cash used for capital expenditures during 2022 as compared with 2021, despite the decrease in cash provided by operating activities from continuing operations during 2022 as compared with 2021, which included a decrease of approximately $255 million in net proceeds associated with the Albemarle Settlement.
The decrease in free cash flow from continuing operations was primarily attributable to a decrease in cash provided by operating activities from continuing operations, partially offset by a decrease in cash used for capital expenditures during 2023 as compared with 2022.
(6) During the year ended December 31, 2022, we established a $49 million significant deferred tax asset valuation allowance in The Netherlands. We eliminated the effect of this significant change in deferred tax asset valuation allowances from our presentation of adjusted net income to allow investors to better compare our ongoing financial performance from period to period.
We eliminated the effect of these significant deferred tax asset valuation allowances from our presentation of adjusted net income to allow investors to better compare our ongoing financial performance from period to period.
Net cash used in investing activities from continuing operations for 2022 and 2021 was $260 million and $508 million, respectively. During 2022 and 2021, we paid $272 million and $326 million, respectively, for capital expenditures, including $100 million during 2021, on a new MDI splitter in Geismar, Louisiana.
Net cash provided by (used in) investing activities from continuing operations for 2023 and 2022 was $309 million and $(260) million, respectively. During 2023 and 2022, we paid $230 million and $272 million, respectively, for capital expenditures.
See “—Segment Analysis” below. ● Our operating expenses and the operating expenses of Huntsman International for the year ended December 31, 2022 decreased by $25 million and $22 million, respectively, or 3% for both, as compared with the 2021 period, primarily related to lower selling, general and administrative costs. ● Restructuring, impairment and plant closing costs for the year ended December 31, 2022 increased by $46 million, or 115%, as compared with the 2021 period.
See “—Segment Analysis” below. ● Our operating expenses, net and the operating expenses, net of Huntsman International for the year ended December 31, 2023 increased by $16 million and $17 million, respectively, or 2% for both, as compared with the 2022 period, primarily related to the negative impact of translating foreign currency amounts to the U.S. dollar and an increase in other operating expenses, partially offset by decreases in selling, general and administrative expenses and research and development expenses. ● Restructuring, impairment and plant closing costs for the year ended December 31, 2023 decreased by $68 million, or 79%, as compared with the 2022 period.
Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed with the SEC on February 15, 2022. 32 Selected Quarterly Financial Data For each of our Company and Huntsman International, the following tables set forth a summary of selected quarterly financial data for the years ended December 31, 2022 and 2021 (dollars in millions).
Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed with the SEC on February 21, 2023.
The decrease in segment adjusted EBITDA was primarily due to lower sales volumes, lower MDI margins in Europe and Asia, the negative impact of weaker major international currencies against the U.S. dollar and lower equity earnings from our minority-owned joint venture in China.
The decrease in segment adjusted EBITDA was primarily due to lower sales volumes, lower MDI margins, the net negative impact of major foreign currency exchange rate movements against the U.S. dollar and a gain from an insurance settlement received in the second quarter of 2022, partially offset by higher equity earnings from our minority-owned joint venture in China and cost savings from our cost optimization programs.
We intend to renew, repay or extend the majority of these short-term facilities in the next twelve months. As of December 31, 2022, we had approximately $619 million of cash and cash equivalents, including restricted cash, held by our foreign subsidiaries, including our variable interest entities.
As of December 31, 2023, we had $12 million classified as current portion of debt, including debt at our variable interest entities of $9 million and certain other short-term facilities and scheduled amortization payments totaling $3 million. We intend to renew, repay or extend the majority of these short-term facilities in the next twelve months.
For an analysis of our segments’ results of operations for the fiscal years ended December 31, 2021 and 2020, see “Part II. Item 7.
Cash Flows For Year Ended December 31, 2022 Compared with Year Ended December 31, 2021 For a comparison of our cash flows for the fiscal years ended December 31, 2022 and 2021, see “Part II. Item 7.
The decrease was primarily attributable to a decrease in income at our PO/MTBE joint venture in China, in which we hold a 49% interest. ● Fair values adjustments to our investment in Venator and the related option to sell our remaining Venator shares was a net loss of $12 million for the year ended December 31, 2022 as compared with a net loss of $28 million in the 2021 period.
Restructuring, Impairment and Plant Closing Costs” to our consolidated financial statements. ● Equity in income of investment in unconsolidated affiliates for the year ended December 31, 2023 increased to $83 million from $67 million in the 2022 period, primarily related to an increase in income at our PO/MTBE joint venture with China, in which we hold a 49% interest. ● We recorded a loss of $5 million in fair value adjustments to our investment in Venator for the year ended December 31, 2023 compared to a loss of $12 million in the 2022 period.
(7) For details regarding the tax impacts of our non-GAAP adjustments, please see the reconciliation of our net income to adjusted net income noted above.
(7) For details regarding the tax impacts of our non-GAAP adjustments, please see the reconciliation of our net income to adjusted net income noted above. 28 Table of Contents Non-GAAP Financial Measures Our consolidated financial statements are prepared in accordance with U.S. GAAP, which we supplement with certain non-GAAP financial information.
Total assets and liabilities held for sale as of December 31, 2022 are classified as current as we anticipate the sale of our Textile Effects Business will close in February 2023. For more information, see “Note 4. Discontinued Operations and Business Dispositions—Discontinued Operations—Sale of Textile Effects Business” to our consolidated financial statements.
For more information, see “Note 4. Discontinued Operations and Business Dispositions—Discontinued Operations—Sale of Textile Effects Business” to our consolidated financial statements.
However, such repatriation may potentially be subject to limited foreign withholding taxes. For more information regarding our debt, see “Note 14.
Nevertheless, we could repatriate additional cash as dividends and the repatriation of cash as a dividend would generally not be subject to U.S. taxation. However, such repatriation may potentially be subject to limited foreign withholding taxes. For more information regarding our debt, see “Note 14.
Associated with this program, we expect cash costs of approximately $65 million, including approximately $15 million of capital expenditures, through 2024. ● On April 29, 2022, a New Orleans jury awarded us approximately $94 million in our long-running court battle against Praxair/Linde, one of the industrial gas suppliers to our Geismar, Louisiana MDI manufacturing site.
Aside from the extended maturity dates, these amendments to our A/R Programs secured substantially similar terms as those in the prior agreements. ` ● On April 29, 2022, a New Orleans jury awarded us approximately $94 million in our long-running court battle against Praxair/Linde, one of the industrial gas suppliers to our Geismar, Louisiana MDI manufacturing site.
MDI average selling prices increased in Europe and the Americas regions. Sales volumes decreased due to lower demand across all our regions and across all markets, other than automotive.
Sales volumes decreased primarily due to lower demand, primarily in the Americas. MDI average selling prices decreased primarily due to less favorable supply and demand dynamics.
Although sales volumes increased in our aerospace market, overall sales volumes decreased due to lower volumes in our non-aerospace markets resulting from deselection of lower margin business and weaker end market demand, particularly in the fourth quarter of 2022. The increase in segment adjusted EBITDA was primarily due to higher sales prices and improved sales mix.
Sales volumes decreased primarily due to reduced customer demand in our infrastructure markets and the deselection of lower margin business. The decrease in segment adjusted EBITDA was primarily due to lower sales volumes.
With the exception of certain amounts that we expect to repatriate in the foreseeable future, we intend to use cash held in our foreign subsidiaries to fund our local operations. Nevertheless, we could repatriate additional cash as dividends and the repatriation of cash as a dividend would generally not be subject to U.S. taxation.
As of December 31, 2023, we had approximately $529 million of cash and cash equivalents, including restricted cash, held by our foreign subsidiaries, including our variable interest entities. With the exception of certain amounts that we expect to repatriate in the foreseeable future, we intend to use cash held in our foreign subsidiaries to fund our local operations.
Average selling prices increased across all product lines primarily in response to an increase in raw material costs. Sales volumes decreased across all regions primarily due to slowing construction activity, fewer wind power installations in China and reduced demand in the coatings, adhesives and other industrial markets.
Performance Products The decrease in revenues in our Performance Products segment for 2023 compared to 2022 was primarily due to lower sales volumes and lower average selling prices. Sales volumes decreased in all regions primarily due to slowing construction activity and reduced demand in coatings and adhesives, agriculture, lubes and other industrial markets.
The increase in adjusted EBITDA from Corporate and other resulted primarily from an increase in unallocated foreign currency exchange gains and a decrease in corporate overhead costs and LIFO valuation losses.
The increase in adjusted EBITDA from Corporate and other resulted primarily from an increase in LIFO valuation gains and a decrease in corporate overhead costs and minority interest expense, partially offset by a decrease in unallocated foreign currency exchange gains. 31 Year Ended December 31, 2022 Compared with Year Ended December 31, 2021 For a comparison of both our results of operations and segment analysis for the fiscal years ended December 31, 2022 and 2021, see “Part II.
The increase in free cash flow from continuing operations was primarily attributable to the increase in cash provided by operating activities from continuing operations, including $332.5 million in proceeds associated with the Albemarle Settlement, partially offset by an increase in cash used for capital expenditures during 2021 as compared with 2020. 34 Table of Contents Changes in Financial Condition The following information summarizes our working capital (dollars in millions): December 31, December 31, (Decrease) Percent 2022 2021 increase change Cash and cash equivalents $ 654 $ 1,041 $ (387 ) (37 )% Accounts and notes receivable, net 834 1,015 (181 ) (18 )% Inventories 995 1,038 (43 ) (4 )% Receivable associated with the Albemarle Settlement — 333 (333 ) (100 )% Other current assets 190 155 35 23 % Current assets held for sale (1) 472 346 126 36 % Total current assets 3,145 3,928 (783 ) (20 )% Accounts payable 961 1,114 (153 ) (14 )% Accrued liabilities 429 713 (284 ) (40 )% Current portion of debt 66 12 54 450 % Current operating lease liabilities 51 49 2 4 % Current liabilities held for sale (1) 194 163 31 19 % Total current liabilities 1,701 2,051 (350 ) (17 )% Working capital $ 1,444 $ 1,877 $ (433 ) (23 )% (1) Held for sale assets and liabilities are those of our Textile Effects Business.
Changes in Financial Condition The following information summarizes our working capital (dollars in millions): December 31, December 31, (Decrease) Percent 2023 2022 increase change Cash and cash equivalents $ 540 $ 654 $ (114 ) (17 )% Accounts and notes receivable, net 753 834 (81 ) (10 )% Inventories 867 995 (128 ) (13 )% Other current assets 154 190 (36 ) (19 )% Current assets held for sale (1) — 472 (472 ) (100 )% Total current assets 2,314 3,145 (831 ) (26 )% Accounts payable 719 961 (242 ) (25 )% Accrued liabilities 395 429 (34 ) (8 )% Current portion of debt 12 66 (54 ) (82 )% Current operating lease liabilities 46 51 (5 ) (10 )% Current liabilities held for sale (1) — 194 (194 ) (100 )% Total current liabilities 1,172 1,701 (529 ) (31 )% Working capital $ 1,142 $ 1,444 $ (302 ) (21 )% (1) Total assets and liabilities held for sale as of December 31, 2022 are classified as current because we completed the sale of our Textile Effects Business on February 28, 2023.
See also “—Cash Flows Year Ended December 31, 2022 Compared with Year Ended December 31, 2021.” ● Accounts and notes receivable, net decreased by $181 million primarily due to lower revenues in the fourth quarter of 2022 compared to the fourth quarter of 2021. ● Inventories decreased by $43 million primarily due to lower inventory costs and volumes. ● Receivable associated with the Albemarle Settlement decreased to nil due to the receipt of the final arbitration award payment of $332.5 million during the second quarter of 2022. ● Accounts payable decreased by $153 million primarily due to lower inventory purchases. ● Accrued liabilities decreased by $284 million primarily due to lower accrued compensation, current income taxes and approximately $200 million of legal fees associated with the Albemarle Settlement, offset by an increase in restructuring and plant closing reserves. ● Current portion of debt increased by $54 million primarily due to net borrowings of $55 million under our 2022 Revolving Credit Facility that are classified as short term. 35 Table of Contents Short-Term Liquidity We depend upon our cash, our 2022 $1.2 billion senior unsecured revolving credit facility (“2022 Revolving Credit Facility”), our U.S. accounts receivable securitization program (“U.S.
See also “—Cash Flows Year Ended December 31, 2023 Compared with Year Ended December 31, 2022.” ● Accounts and notes receivable, net decreased by $81 million primarily due to lower revenues in the fourth quarter of 2023 compared to the fourth quarter of 2022. ● Inventories decreased by $128 million primarily due to lower inventory costs and volumes. ● Other current assets decreased by $36 million primarily due to amortization of deferred charges related to insurance premiums and a decrease in current income taxes receivable. ● Accounts payable decreased by $242 million primarily due to lower inventory purchases. ● Accrued liabilities decreased by $34 million primarily due to a decrease in accrued compensation costs and accrued restructuring costs. ● Current portion of debt decreased by $54 million primarily due to the repayment in full of the outstanding balance under our 2022 Revolving Credit Facility. 32 Table of Contents Short-Term Liquidity We depend upon our cash, our 2022 Revolving Credit Facility, our A/R Programs and other debt instruments to provide liquidity for our operations and working capital needs.
(4) The income tax impacts, if any, are computed on the pre-tax adjustments using a with and without approach. (5) In addition to income tax impacts, this adjusting item is also impacted by depreciation and amortization expense and interest expense.
(5) In addition to income tax impacts, this adjusting item is also impacted by depreciation and amortization expense and interest expense. (6) During the years ended December 31, 2023 and 2022, we established a $14 million and a $49 million significant deferred tax asset valuation allowance in the U.K. and the Netherlands, respectively.
Discontinued Operations and Business Dispositions—Separation and Deconsolidation of Venator” to our consolidated financial statements. ● Loss on early extinguishment of debt was nil for the year ended December 31, 2022 as compared with $27 million in the 2021 period, primarily due to the redemption in full of our 2022 Senior Notes in the second quarter of 2021. See “Note. 14.
Discontinued Operations and Business Dispositions—Separation and Deconsolidation of Venator” to our consolidated financial statements. ● Our other income, net for the year ended December 31, 2023 was $2 million as compared with $35 million in the 2022 period, and the other income, net of Huntsman International for the year ended December 31, 2023 was $2 million as compared with $34 million in the 2022 period, primarily related to an increase in certain periodic pension costs, partially offset by a decrease in certain legal related expenses. ● Our income tax expense for the year ended December 31, 2023 decreased to $64 million from $186 million in the 2022 period.
During 2021, we received $43 million for the sale of businesses, primarily due to the receipt of $28 million pursuant to an earnout provision in connection with the sale of our India-based DIY business. See “Note 4. Discontinued Operations and Business Dispositions—Sale of India-Based Do-It-Yourself Consumer Adhesives Business” to our consolidated financial statements.
During 2023, we received $544 million for the sale of businesses, net, primarily related to net proceeds of $530 million from the sale of our Textile Effects Business. See “See “Note 4. Discontinued Operations—Sale of Textile Effects Business” to our consolidated financial statements. Net cash used in financing activities for 2023 and 2022 was $620 million and $994 million, respectively.
A/R Program”) and European accounts receivable securitization program (“EU A/R Program” and collectively with the U.S. A/R Program, “A/R Programs”) and other debt instruments to provide liquidity for our operations and working capital needs.
A/R Program”) and European accounts receivable securitization program (“EU A/R Program” and collectively with the U.S. A/R Program, “A/R Programs”). During 2022, we had net borrowings of $219 million under our 2022 Revolving Credit Facility. Free cash flow from continuing operations for 2023 and 2022 were proceeds of cash of $21 million and $620 million, respectively.
(3) Includes costs associated with transition activities relating primarily to our Corporate program to optimize our global approach to leverage shared services capabilities as well as our 2020 acquisition of CVC Thermoset Specialties, a North American specialty chemical manufacturer serving the industrial composites, adhesives and coatings markets (“CVC Thermoset Specialties Acquisition”).
(3) Includes costs associated with transition activities relating primarily to our Corporate program to optimize our global approach to leverage shared services capabilities and managed services in various information technology functions. (4) The income tax impacts, if any, are computed on the pre-tax adjustments using a with and without approach.
Net cash used in financing activities for 2022 and 2021 was $994 million and $977 million, respectively. During 2022 and 2021, we paid $1,005 million and $200 million for repurchases of our common stock, respectively. During 2022, we had net borrowings of $219 million under our 2022 Revolving Credit Facility.
During 2023 and 2022, we paid $349 million and $1,005 million for repurchases of our common stock, respectively. During 2023, we repaid $51 million against the outstanding balances under our 2022 $1.2 billion senior unsecured revolving credit facility (“2022 Revolving Credit Facility”) and our U.S. accounts receivable securitization program (“U.S.